SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as investors digest news of warrant distributions to shareholders, a move perceived by some as a strategic alignment of management incentives while others fear potential dilution. Community members are debating the implications of these warrants, particularly how they might impact the stock's price and future partnerships, especially a speculated collaboration with Robinhood ($HOOD). The broader discussion revolves around Opendoor's long-term vision, its shift towards becoming a technology-driven marketplace for real estate, and its ability to navigate a challenging housing market.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is active following shareholder approval of Elon Musk's compensation package, sparking debate about the company's future and Musk's role. Community discussions revolve around ambitious targets tied to the package, including market cap growth and robotaxi deployment. Some traders anticipate increased volatility and a potential short squeeze, while others express skepticism about the company's valuation and long-term prospects.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending amid discussions around a recent capital raise and the acquisition of Hawthorne Airport, sparking debates about dilution and strategic implications. Community members are weighing the potential benefits of the airport acquisition against concerns over cash burn and management decisions. Speculation about partnerships, particularly with Tesla, and upcoming earnings are also fueling active discussions.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending amid a new partnership with ESPN and anticipation for upcoming earnings, though some express concerns about increased spending and competition from prediction markets. Community discussions revolve around the deal's potential impact, the company's profitability, and whether it can maintain its market position. Some investors are optimistic about long-term growth, while others cite recent disappointing results and a challenging economic climate.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SOUN is trending as investors discuss the company's recent earnings report and future profitability, with community members highlighting a beat on expectations and a raised full-year outlook. Despite positive results, the stock's price action is generating mixed sentiment, as some express concerns about broader market conditions and potential government shutdowns impacting performance. Optimistic investors focus on SoundHound's AI technology, partnerships, and long-term growth potential in the rapidly expanding AI sector.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following its Q3 2025 earnings report, which highlighted significant revenue growth and positive margins, alongside a mention of continued progress in their relationship with Amazon. The community is dissecting the earnings call for insights on future prospects, particularly regarding potential Amazon partnerships and government/army deals. Bullish sentiment revolves around the company's growth trajectory, zero debt, and potential for significant returns in the coming years, while some are wary of broader market conditions impacting the stock.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTD is trending amid discussions around its recent earnings and their implications, with community members debating the company's performance and future outlook. There is active discussion about Amazon's competitive presence in the ad tech space, as well as whether TTD can capitalize on growth opportunities, particularly in CTV. Despite some positive sentiment, concerns persist regarding the company's long-term performance.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors grapple with the stock's recent sharp decline and speculate on potential catalysts. Community discussions revolve around the upcoming earnings report and the impact of U.S.-China trade relations on the rare earth market, with some highlighting long-term growth potential amid concerns about near-term volatility and Chinese competition.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending amid discussions about its earnings report and a significant drop in stock price, despite strong revenue growth; the community is focused on understanding the impact of a one-time distributor termination cost and its relationship with Pepsi. Some traders see this dip as a buying opportunity, while others express concerns about management and potential market manipulation, comparing it to competitor Monster Energy's performance.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer ($PFE) is trending amid a bidding war with Novo Nordisk ($NVO) for Metsera, an obesity drug developer, with the community debating the strategic value and potential overpayment. Discussions also revolve around Pfizer's upcoming earnings, dividend payouts, and the implications of a lawsuit filed against Metsera and Novo Nordisk. Some traders express frustration with the stock's price action and discuss options strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates

MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates

Shares of Affimed N.V. (AFMD) were in the spotlight on Monday morning after the company received a notice from Nasdaq indicating a compliance issue with its stock price.Affirmed <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/04/21/3064526/0/en/Affimed-Announces-Receipt-of-NASDAQ-Deficiency-Notice-Regarding-Minimum-Bid-Price-Requirement.html">said</a> that the Nasdaq notice indicated the bid price for the company’s common shares had closed below the minimum $1.00 per share requirement for continued listing on the bourse.Affirmed, headquartered in Mannheim, Germany, stated that it has been granted an initial period of 180 calendar days, or until October 13, 2025, to regain compliance.The company said that if it fails to regain compliance with the Minimum Bid Price Rule during the period, it may consider applying to transfer its securities from The Nasdaq Global Select Market to The Nasdaq Capital Market, provided that it meets the requirements.Affirmed also added that there is no assurance that Nasdaq would grant the company’s request for continued listing in the case.In the meantime, the firm intends to monitor the bid price of its common shares and consider available options to regain compliance with the Minimum Bid Price Rule.Affimed is a clinical-stage company aimed at developing treatments for cancer. In December, the company announced positive updates from a trial of its AFM24 in combination with atezolizumab in Non-Small Cell Lung Cancer patients.AFM24 is an innate cell engager molecule that activates the innate immune system to kill cancer cells.On Stocktwits, retail sentiment regarding Affimed remained unchanged within ‘neutral’ territory over the past 24 hours, while message volume remained at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:648/146;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_21_at_7_06_18_AM_png_68fb6a412b.webp" alt="AFMD's Sentiment Meter and Message Volume as of 7:20 a.m. ET on April 21, 2025 | Source: Stocktwits" width="648" height="146"><figcaption>AFMD's Sentiment Meter and Message Volume as of 7:20 a.m. ET on April 21, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/AFMD">AFMD stock</a> is down by about 46% so far this year and by over 85% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dhl-freezes-shipments-worth-over-800-to-us-consumers-amid-rising-trade-tensions/chQiW2kRbQO">DHL Freezes Shipments Worth Over $800 To US Consumers Amid Rising Trade Tensions</a>For updates and corrections, email newsroom[at]stocktwits[dot]com&nbsp;

Global stock market chart and trading board - stock photo

Affimed Receives Nasdaq Deficiency Notice Over Low Share Price: Retail’s In Wait-And-Wait Mode

The company has been granted an initial period of 180 calendar days, or until October 13, 2025, to regain compliance with Nasdaq’s Minimum Bid Price Rule.

Equity

Q4 2023 Affimed NV Earnings Call Transcript

Affimed Reports 2023 Financial Results and Operational Progress

AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer (NSCLC) EGFR-wildtype cohort: one complete...

Aper u : B n fices de Affimed

Affimed (NASDAQ:AFMD) va annoncer ses derniers b n fices ce jeudi. Suivez les tendances du march , avec l'aper u des b n fices du quatri me trimestre de Affimed de Benzinga.
R sultat net, b n fices...

Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024

MANNHEIM, Germany, March 21, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) ( Affimed or the Company ), a clinical-stage immuno-oncology company committed to giving patients back their...

Affimed Announces 1-for-10 Reverse Stock Split

MANNHEIM, Germany, March 06, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) ( Affimed or the Company ), a clinical-stage immuno-oncology company committed to giving patients back their...

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

Data update from AFM24-102 Phase 1/2a combination study includes 15 heavily pre-treated patients from the EGFR-wildtype (wt) non-small cell lung cancer (NSCLC) expansion cohortFollow-up shows three...

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.

Affimed N.V.

$HOOD

$ELF

$DUOL

$CELH

Which of these post-earnings decliners are you most interested in buying?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '25	-$0.40	--	--	N/A
Q4 '24	-$0.65	--	--	N/A
Q3 '24	-$1.03	-$1.09	-5.34%	MISSED
Q2 '24	-$1.08	-$1.07	1.61%	BEAT
Q1 '24	-$1.66	-$1.41	15.36%	BEAT

AFMD
Affimed N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '24

Historical Earnings

Latest AFMD News

AFMDAffimed N.V.